4//SEC Filing
Omrix Biopharmaceuticals, Inc. 4
Accession 0001209191-08-002277
CIK 0001349426operating
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 11:15 AM ET
Size
6.6 KB
Accession
0001209191-08-002277
Insider Transaction Report
Form 4
Burshtine Michael
Senior VP and CFO
Transactions
- Exercise/Conversion
Common Stock
2008-01-04$6.19/sh+32,665$202,196→ 32,665 total - Sale
Common Stock
2008-01-04$34.00/sh−32,665$1,110,610→ 0 total
Documents
Issuer
Omrix Biopharmaceuticals, Inc.
CIK 0001349426
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349426
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 11:15 AM ET
- Size
- 6.6 KB